CN103110849A - Traditional Chinese medicine pill for treating hyperlipidemia caused by stagnation of phlegm-dampness - Google Patents
Traditional Chinese medicine pill for treating hyperlipidemia caused by stagnation of phlegm-dampness Download PDFInfo
- Publication number
- CN103110849A CN103110849A CN2012105295005A CN201210529500A CN103110849A CN 103110849 A CN103110849 A CN 103110849A CN 2012105295005 A CN2012105295005 A CN 2012105295005A CN 201210529500 A CN201210529500 A CN 201210529500A CN 103110849 A CN103110849 A CN 103110849A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- phlegm
- traditional chinese
- pill
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine pill for treating hyperlipidemia caused by the stagnation of phlegm-dampness, belonging to the technical field of a traditional Chinese medicine. The traditional Chinese medicine pill comprises the following raw materials in parts by weight: 5 parts of hawthorn, 3 parts of radix astragali, 2 parts of motherwort herb, 5 parts of coix seed, 2 parts of pinellia ternate, 2 parts of tangerine peel, 2 parts of white mustard seed and 5 parts of cassia twig. The traditional Chinese medicine pill has the effects of expelling phlegm, resolving turbidity, promoting qi circulation and relieving depression. The pill has the characteristics of accurate curative effect, high curative ratio, short course of treatment, no toxicity and no side effect.
Description
Technical field
The invention belongs to the Chinese medicine field, relate to a kind of medicine pill for the treatment of phlegm resistance type hyperlipidemia.
Background technology
Hyperlipidemia is a common metabolic disturbance diseases, be also a kind of person in middle and old age's commonly encountered diseases, frequently-occurring disease, is to cause cardiovascular and cerebrovascular disease as hypertension, coronary heart disease, cerebrovascular accident, the key factor that alzheimer disease etc. are sick; Belong to the categories such as Chinese medicine " phlegm-damp ", " dizzy " according to clinical symptoms; Wherein the hypertensive pathogenesis of phlegm resistance type is deficiency in origin and excess in superficiality, simulataneous insufficiency and excessive, and treatment should be distinguished deficiency and excess, conditioning viscera function; The generation of primary disease is normal relevant with diet, feelings will, the factor such as get old and weak.By dialectical, taking expelling phlegm and resolving turbidity, promoting QI circulation for relieving depression in clinical is principle for the treatment of, has obtained effect preferably.
Summary of the invention
The purpose of this invention is to provide a kind of medicine pill for the treatment of phlegm resistance type hyperlipidemia, have that determined curative effect, cure rate are high, short treating period and the characteristics that have no side effect.
The present invention treats the medicine pill of phlegm resistance type hyperlipidemia, and the weight of raw material of Chinese medicine consists of: 5 parts of 5 parts of Fructus Crataegis, 3 parts of the Radixs Astragali, 2 parts of Herba Leonuris, 5 parts of Semen Coicis, 2 parts of the Rhizoma Pinelliaes, 2 parts of Pericarpium Citri Reticulataes, 2 parts of Semen Sinapis Albaes and Ramulus Cinnamomi.
The medicine pill that the present invention treats phlegm resistance type hyperlipidemia is the watered pill.
Preparation method: will add medicine to and concoct qualified, weighing and assort, and roll altogether and be fine powder, and even, cross thin sieve of 80-100 order, with cold boiled water with medicated powder general be piller, dry or cold drying, pill light circle is neat, color and luster is consistent, packs every bag heavy 10 grams.
Usage and consumption: take pill, (10 gram) once a bag, and day takes secondary, and 30 days is a course for the treatment of, serve on three courses for the treatment of.
Drug action mechanism in the present invention is as follows:
Fructus Crataegi: promoting digestion and removing stagnation, promoting QI to circulate and dispersing the agglomeration of the pathogens, blood circulation promoting and blood stasis dispelling, this product is warm in nature, the QI and blood of passing through, and the merit of blood circulation promoting and blood stasis dispelling, pain relieving is arranged.
The Radix Astragali: tonifying Qi and lifting yang, benefit are defended consolidating superficial resistance, inducing diuresis to remove edema, promoting pus discharge and tissue regeneration strengthening.
Herba Leonuri: promoting blood circulation to restore menstrual flow, inducing diuresis to remove edema.
Semen Coicis: promoting diuresis to eliminate damp pathogen, spleen invigorating, eliminating impediment, clearing away heat and discharging pus.
The Rhizoma Pinelliae: drying dampness to eliminate phlegm, stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass, externally used detumescence pain relieving.This product is hot warm and dry, is drying dampness to eliminate phlegm, the key medicine of warming for resolving cold-phlegm, the kind damp-phlegm of controlling internal organs.
Pericarpium Citri Reticulatae: regulating qi-flowing for strengthening spleen, drying dampness to eliminate phlegm.
Semen Sinapis Albae: warming the lung for resolving phlegm, promoting the circulation of QI eliminating stagnation.
Ramulus Cinnamomi: relieving the exterior syndrome by diaphoresis, promoting the flow of QI-blood by warming the meridian, supporing yang activating QI.
Above all medicine effects and cure mainly and all be referred to college of traditional Chinese medicine's undergraduate course teaching material sixth version " Chinese materia medica ", Science and Technology of Shanghai publishing house.
Below sum up for clinical trial:
The symptom of phlegm resistance type hyperlipidemia: the long-term vertigo, heaviness of the head as if it were tightly bandaged, numb limbs and tense tendons, chest distress, fatigue and weakness, refreshing, drowsiness, the obesity of nothing, the profound cunning of arteries and veins or heavy.
The treatment standard:
Recovery from illness: symptom disappears fully, and chemical examination lipid examination indices is all in normal range.
Take a turn for the better: subjective symptoms obviously alleviates, and chemical examination lipid examination indices all has decline in various degree.
Invalid: subjective symptoms alleviates, and chemical examination lipid examination indices all exceeds normal value.
Therapeutic outcome: clinical trial treatment phlegm resistance type hyperlipemic patients 180 examples.Recovery from illness 120 examples, account for 67% after three course of therapy, and 50 examples that take a turn for the better account for 28%, and invalid 10 examples account for 5%, total effective rate 95%.Without any untoward reaction, three large routine tests and hepatic and renal function detect no abnormal by the treatment patient.
Below enumerate several model cases:
Case 1: patient Lee so-and-so, the man, 50 years old, because of long-term dizziness headache, limbs fatigue, numb limbs and tense tendons etc., the blood fat indices was all higher than normal value, examined at local hospital in May, 2009 to be hyperlipidemia.Oral administration Western medicine lipid-lowering therapy half a year is without positive effect; Examine my institute in May, 2010, oral administration Drug therapy of the present invention after three courses for the treatment of symptom all disappear, blood biochemical analysis blood fat indices all recovers normal.Follow up a case by regular visits to not recurrence in a year.
Case 2: patient Liu so-and-so, the female, 57 years old, suffered from hyperlipidemia more than 2 years, multi-treatment is invalid.Examine my institute in July, 2010, after oral administration medicine of the present invention was treated three courses for the treatment of, blood biochemical analysis blood fat indices was all normal, and subjective symptoms is improved.Follow up a case by regular visits to not recurrence in a year.
Case 3: patient Zhang, the man, 62 years old, suffered from hyperlipidemia more than 8 years, long-term treatment, heavy when light during the state of an illness, blood fat often exceeds normal value.Fully recover three courses for the treatment of after in my institute's oral administration Drug therapy of the present invention in August, 2010.Follow up a case by regular visits to not recurrence in a year.
Compared with prior art, have following beneficial effect:
(1) the selected medicine of the present invention all meets Pharmacopoeia of the People's Republic of China regulation.The present invention has the effect of the removing dampness of eliminating the phlegm and promoting QI circulation for relieving depression according to compatibility.
(2) the present invention not only has therapeutical effect preferably to phlegm resistance type hyperlipidemia, and the generation of prevention hyperlipidemia is also had good effect.
(3) rigorous, the determined curative effect of prescription of the present invention, instant effect, short treating period, nontoxic.
The specific embodiment
The invention will be further described below in conjunction with embodiment.
Embodiment
The weight of raw material of Chinese medicine consists of:
5 parts of 5 parts of Fructus Crataegis, 3 parts of the Radixs Astragali, 2 parts of Herba Leonuris, 5 parts of Semen Coicis, 2 parts of the Rhizoma Pinelliaes, 2 parts of Pericarpium Citri Reticulataes, 2 parts of Semen Sinapis Albaes and Ramulus Cinnamomi.
Preparation method: will add medicine to and concoct qualified, weighing and assort, and roll altogether and be fine powder, and even, cross thin sieve of 80-100 order, with cold boiled water with medicated powder general be piller, dry or cold drying, pill light circle is neat, color and luster is consistent, packs every bag heavy 10 grams.Oral, once a bag, day takes secondary, and 30 days is a course for the treatment of, serve on three courses for the treatment of.
Claims (2)
1. a medicine pill for the treatment of phlegm resistance type hyperlipidemia, is characterized in that, the weight of raw material of Chinese medicine consists of: 5 parts of 5 parts of Fructus Crataegis, 3 parts of the Radixs Astragali, 2 parts of Herba Leonuris, 5 parts of Semen Coicis, 2 parts of the Rhizoma Pinelliaes, 2 parts of Pericarpium Citri Reticulataes, 2 parts of Semen Sinapis Albaes and Ramulus Cinnamomi.
2. the medicine pill for the treatment of phlegm resistance type hyperlipidemia according to claim 1, is characterized in that, the medicine pill for the treatment of phlegm resistance type hyperlipidemia is the watered pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012105295005A CN103110849A (en) | 2012-12-10 | 2012-12-10 | Traditional Chinese medicine pill for treating hyperlipidemia caused by stagnation of phlegm-dampness |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012105295005A CN103110849A (en) | 2012-12-10 | 2012-12-10 | Traditional Chinese medicine pill for treating hyperlipidemia caused by stagnation of phlegm-dampness |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103110849A true CN103110849A (en) | 2013-05-22 |
Family
ID=48409257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012105295005A Pending CN103110849A (en) | 2012-12-10 | 2012-12-10 | Traditional Chinese medicine pill for treating hyperlipidemia caused by stagnation of phlegm-dampness |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103110849A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101028392A (en) * | 2007-04-16 | 2007-09-05 | 北京艺信堂医药研究所 | Chinese medicine for treating hyperlipemia |
| CN102343053A (en) * | 2011-10-19 | 2012-02-08 | 成都绿迪科技有限公司 | Traditional Chinese medicine for treating hyperlipemia |
-
2012
- 2012-12-10 CN CN2012105295005A patent/CN103110849A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101028392A (en) * | 2007-04-16 | 2007-09-05 | 北京艺信堂医药研究所 | Chinese medicine for treating hyperlipemia |
| CN102343053A (en) * | 2011-10-19 | 2012-02-08 | 成都绿迪科技有限公司 | Traditional Chinese medicine for treating hyperlipemia |
Non-Patent Citations (2)
| Title |
|---|
| 《现代中西医结合杂志》 20110731 周红军 等 "中药治疗高血脂症的临床研究进展" , 第20期 * |
| 周红军 等: ""中药治疗高血脂症的临床研究进展"", 《现代中西医结合杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101874867A (en) | Chinese medicinal preparation for treating psoriasis | |
| CN102240380A (en) | Traditional Chinese medicine preparation for treating senile vascular dementia | |
| CN102058784A (en) | Medicinal composition for treating pulmonary heart disease and application thereof | |
| CN105168917A (en) | Traditional Chinese medicine preparation for treating scapulohumeral periarthritis and preparation method of traditional Chinese medicine preparation | |
| CN102058802A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis | |
| CN103100039A (en) | Traditional Chinese medicine pill for treating yin-deficiency and fire-hyperactivity type insomnia | |
| CN105250890A (en) | Traditional Chinese medicine for treating hyperlipidemia | |
| CN102125678B (en) | Chinese medicinal preparation for treating hysteria disease | |
| CN103830523A (en) | Traditional Chinese medicine composition for treating epidemic cerebrospinal meningitis | |
| CN103110876A (en) | Traditional Chinese medicine preparation for treating heart qi deficiency type bradycardia | |
| CN102406850A (en) | Traditional Chinese preparation for treating senile dementia | |
| CN103212019B (en) | Chinese materia medica preparation for treating depression | |
| CN101433663A (en) | Chinese medicine for treating cough | |
| CN101085157A (en) | Traditional Chinese medicine preparation for treating chronic nephritis | |
| CN103110849A (en) | Traditional Chinese medicine pill for treating hyperlipidemia caused by stagnation of phlegm-dampness | |
| CN103638397B (en) | Treat pachydermic cachectic Chinese medicine preparation | |
| CN103638431B (en) | The Chinese medicine preparation for the treatment of muscle cramp | |
| CN103127283A (en) | Medicine for treating pelvic inflammation | |
| CN103099879A (en) | Traditional Chinese medicine (TCM) preparation for treating fifth-watch diarrhea | |
| CN103110710B (en) | Traditional Chinese medicine pill for treating spontaneous perspiration | |
| CN103212039A (en) | Traditional Chinese medicine composition for treating infantile cough caused by qi deficiency | |
| CN103446262A (en) | Traditional Chinese medicine for treating senile rectocele | |
| CN102133343B (en) | Traditional Chinese medicine preparation for treating Meniere disease | |
| CN102406913A (en) | Chinese medicinal composition for treating melancholia | |
| CN102178865B (en) | Chinese medicinal herbal composition for treating nasosinusitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130522 |